Proteins inform survival-based differences in patients with glioblastoma

BACKGROUND: Improving the care of patients with glioblastoma (GB) requires accurate and reliable predictors of patient prognosis. Unfortunately, while protein markers are an effective readout of cellular function, proteomics has been underutilized in GB prognostic marker discovery. METHODS: For this...

Descripción completa

Detalles Bibliográficos
Autores principales: Stetson, L C, Ostrom, Quinn T, Schlatzer, Daniela, Liao, Peter, Devine, Karen, Waite, Kristin, Couce, Marta E, Harris, Peggy L R, Kerstetter-Fogle, Amber, Berens, Michael E, Sloan, Andrew E, Islam, Mohammad M, Rajaratnam, Vilashini, Mirza, Shama P, Chance, Mark R, Barnholtz-Sloan, Jill S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212893/
https://www.ncbi.nlm.nih.gov/pubmed/32642694
http://dx.doi.org/10.1093/noajnl/vdaa039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212893/
https://www.ncbi.nlm.nih.gov/pubmed/32642694
http://dx.doi.org/10.1093/noajnl/vdaa039

Ejemplares similares